变性高效液相色谱法检测多种途径获取的非小细胞肺癌组织表皮生长因子受体基因突变

BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR) is the most important therapeutic target in non-small cell lung cancer (NSCLC). EGFR mutations may predict responsiveness to tyrosine kinase inhibitors (TKIs). These mutations are commonly identified using direct sequencing, which is...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2010
Materias:
临床研究
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000339/
https://www.ncbi.nlm.nih.gov/pubmed/20840812
http://dx.doi.org/10.3779/j.issn.1009-3419.2010.09.03

Ejemplares similares

Ejemplares similares